Cell line · CVCL_0042
Papers443
3 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
1 to 20 of 443
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Targeting tankyrase scaffolding in the β-catenin destruction complex by PROTAC overcomes the limitation of catalytic inhibitors in colorectal cancer. | Elife | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Pathogenic autoantibodies targeting DNA repair proteins are shared by cancer patients and healthy children later diagnosed with cancer. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting GPX4 and FSP1 to exploit ferroptotic vulnerability in Ewing sarcoma. | Front Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The ROCK1 PHC1 domain mediates recruitment to Rho activity zones and contractility signaling. | Life Sci Alliance | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Aberrant Accumulation of Cyclin D1 Rewires Glutamine Metabolism and Generates a Metabolic Vulnerability in Squamous Cell Carcinoma. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| An inertial-based spiral device for separating rare tumor cells from liquid biopsies. | Bioeng Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Intravenously deliverable oncolytic virus VET3-TGI favorably alters the tumor microenvironment. | J Immunother Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A guide to selecting high-performing antibodies for Netrin-1 (UniProt ID: O95631) for use in western blot and immunoprecipitation. | F1000Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Integrative proteomics defines FANCA as a multifunctional hub linking DNA repair to translation. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| USP5 acts as a proteolytic switch to control SDE2 function via UBL-directed cleavage. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Paclitaxel induces NM2-dependent cellular contraction through GEF-H1 dissociation from microtubules and RhoA/ROCK activation in cancer cells. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CDC7 and APC/CCdh1 gate distinct routes to initiate DNA replication. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CDT1 acts with the replisome to remodel replication forks. | Sci Adv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Structure-based scaffold hopping reveals strategies to overcome oncogenic KIT and PDGFRA mutation-driven drug-resistance in GIST. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Systematic Targeting of Protein Complexes with Molecular COUPLrs. | Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Oxidative base damage to telomeres sensitizes cancer cells to ATR inhibition. | Commun Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Schlafen 11 Is Overexpressed in Multiple Myeloma and Undergoes Nucleolar Translocation in Response to Bortezomib. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Centrosome linker protein CEP68 modulates cellular stress responses via nuclear condensate formation and HSP27 interaction. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Prognostic characteristics of disulfidptosis-related genes across cancers and their potential implications in osteosarcoma. | Sci Prog | 2026 | Its Methods give the RRID and name the line | PubMed | |
| DHX9 transcriptional upregulation and lactylation at K1024 fuels a glycolysis-histone lactylation loop in osteosarcoma. | J Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0042/papers